Series A Round

Isomorphic Labs is a London-based company that leverages artificial intelligence for computational drug design, aiming to transform the drug discovery process and accelerate the development of life-changing medicines. The company utilizes advanced machine learning techniques to predict molecular interactions and optimize drug candidates, significantly reducing the time and cost associated with traditional drug development methods.